Skip to content

ADMA Biologics

US · ADMA #2705 by market cap Listed 1970
13.17 -0.17 -1.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About ADMA Biologics

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Founded
2004
CEO
Mr. Adam S. Grossman
Employees
647
Headquarters
Ramsey, New Jersey, United States of America
Fiscal year end
12-31
Website
admabiologics.com

Company profile

Exchange
US
Symbol
ADMA
Market-cap rank
#2705
Listing date
1970-01-01
Market cap
2.92B
Float cap
2.70B
Shares out
221.85M
Float shares
205.22M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ADMA Biologics discussion 0 comments

Add a comment